NCT00875862

Brief Summary

Research study to determine if putting local anesthetic through a tiny tube next to the nerves that go to the shoulder will improve shoulder range-of-motion following the shoulder procedure performed on the frozen shoulder. It will also help determine if patients have a higher quality-of-life and less pain, require fewer pain pills, experience fewer sleep disturbances, and are more satisfied with their post-procedure pain control.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2008

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 6, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

July 25, 2019

Status Verified

July 1, 2019

Enrollment Period

1 year

First QC Date

April 3, 2009

Last Update Submit

July 23, 2019

Conditions

Keywords

UCSDpainquality-of-liferange-of-motioninterscalene catheternerve blockshoulderShoulder Manipulation

Outcome Measures

Primary Outcomes (1)

  • Passive glenohumeral abduction, as evaluated using standard goniometry restricting scapular movement in a supine position. The difference in abduction the day following manipulation compared with the pre-manipulation value, expressed as a percentage.

    change from baseline: measured immediately prior to manipulation and the morning following the manipulation.

Study Arms (2)

1. 0.2% Ropivicaine perinueral infusion

ACTIVE COMPARATOR

Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy). They will then be randomized to 0.2% Ropivicaine attached to the perineural catheter and an infusion will be initiated. The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.

Procedure: Interscalene catheter with Ropivicaine or normal saline

2. Normal Saline perineural infusion

PLACEBO COMPARATOR

Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy). They will then be randomized to normal saline attached to the perineural catheter and an infusion will be initiated. The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.

Procedure: Interscalene catheter with Ropivicaine or normal saline

Interventions

Patients will be randomized to one of two groups: 0.2% Ropiviciane or normal saline in the infusion pump, following a shoulder manipulation for adhesive capsulitis. The patients will be followed by doctors and study staff to assess pain, range-of-motion and quality-of-life.

1. 0.2% Ropivicaine perinueral infusion2. Normal Saline perineural infusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing theraputic manipulation for adhesive capsulitis of the shoulder
  • age 18 years or older
  • accepting a single-injection nerve block for manipulation
  • understanding possible perineural infusion-related complications, study protocol, and catheter/pump care
  • having caretaker through the first night after manipulation
  • having an ASA physical status classification of 1-3

You may not qualify if:

  • Any contraindications for a CISB
  • any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery
  • known allergy or other contraindication to the study medications
  • pregnancy
  • known hepatic or renal insufficiency/disease
  • peripheral neuropathy of the surgical extremity
  • morbid obesity
  • inability to communicate with the investigators and hospital staff
  • moderate-to-severe shoulder arthritis
  • immunocompromised status of any etiology
  • incarceration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSD Medical Center

San Diego, California, 92103, United States

Location

Related Publications (1)

  • Malhotra N, Madison SJ, Ward SR, Mariano ER, Loland VJ, Ilfeld BM. Continuous interscalene nerve block following adhesive capsulitis manipulation. Reg Anesth Pain Med. 2013 Mar-Apr;38(2):171-2. doi: 10.1097/AAP.0b013e318283475b. No abstract available.

MeSH Terms

Conditions

BursitisPain, PostoperativePain

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Brian M Ilfeld, M.D., M.S.

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology, In Residence

Study Record Dates

First Submitted

April 3, 2009

First Posted

April 6, 2009

Study Start

September 1, 2008

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

July 25, 2019

Record last verified: 2019-07

Locations